Chemical Structure (Pregabalin 01)
Pregabalin Solution
Product Images NDC 39328-090
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 39328-090). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Patrin Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Pregabalin 02)
Figure 2 (Pregabalin 03)
This document appears to be a chart or a graph showing the percentage of patients who improved while taking either pregabalin 100 mg three times a day or a placebo. The text indicates that 100% of patients improved while taking pregabalin, while 0% improved while taking a placebo. There is also a percentage improvement score given, showing that patients experienced a 290% improvement while taking pregabalin. However, due to the lack of context and formatting, it is difficult to determine what the patients were being treated for or the source of the data.*
Figure 3 (Pregabalin 04)
Figure 4 (Pregabalin 05)
Figure 5 (Pregabalin 06)
The text presents a chart showing the percentage of patient improvement with different medications. The chart includes three medications: Pregatalin 100 mG three times a day, Pregatalin 80 mg three times a day, and placebo. The chart also shows the percentage improvement in pain from baseline. The X-axis shows the percentage points, ranging from 0 to 100, and the Y-axis shows the medication names.*
Figure 6 (Pregabalin 07)
Figure 7 (Pregabalin 08)
Figure 8 (Pregabalin 09)
This is a table that demonstrates responder rates for three groups over a period of time. The three groups consisted of a placebo, 2.5 mg/kg/day, and 10 mg/kg/day. The responder rate is shown as a percentage, and the number of responders in each group is shown beneath the percentages.*
Figure 9 (Pregabalin 10)
This is a chart displaying the percentage of patients who improved with different daily doses of Pregabalin for pain relief. There are three doses mentioned: 450mg, 200mg, and an unknown dose referred to as "S - Pregabalin 100mg daily dose". The chart also displays the percentage improvement in pain from baseline.*
Figure 10 (Pregabalin 11)
Figure 11 (Pregabalin 12)
Figure 12 (Pregabalin 13)
The table shows the percentage of subjects who improved from the baseline to week 16 using Pregabalin compared to Placebo. The data is presented in ranges of >0, 210-290, and 100.*
Principal Display Panel (473 mL Bottle Label)
This is a prescription drug called Pregabalin in the form of an Oral Solution. The medication guide should always be dispensed with it. It is for oral use only and each mL contains 20 mg of pregabalin. It should be stored in a tight, child-resistant container at a temperature between 20-25°C (68 to 77°F) with excursions permitted between 15-30°C (59 to 86°F). The usual dosage can be found in the package insert. This product is manufactured by Patrin Pharma based in Skokie, IL, USA. For more information about the product, call (800) 936 3088 or visit www.patrinpharma.com.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
